StockWatch
·

TIME TECHNOPLAST LTD. Q2 FY27 Results

TIMETECHNOQ2 FY27 Results
Filing
Result:Very Good· Market: Flat#Margin squeeze

Outlook: Optimistic · Guidance: Raised

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.0K17.8%32.0%
Total Income2.0K17.9%32.0%
Expenditure1.8K17.1%32.7%
PBT197.6925.5%26.2%
Net Profit148.3125.8%26.5%
OPM13.19%0.06pp1.55pp
NPM7.43%0.47pp0.32pp
EPS2.9626.0%16.5%
View full financials

Revenue grew a strong 32% YoY with PAT up 26.5%, but OPM compressed ~155bps (14.74%→13.19%), making this healthy but not top-tier for an industrial manufacturer.

TIME TECHNOPLAST · Q2 FY27 · THE VERDICT

Record Delivery Beats Full-Year Guidance—Now the Street Tests Execution

Time Technoplast delivered Q2 PAT of ₹148 Cr (+27% YoY), beating its own full-year PAT growth guidance of 23–24% in a single quarter. Management raised guidance. The call reveals why—and where the real risk sits.

13 Nov 2026 · 6 min read
Q2 PAT

₹148.3 Cr

+26.5% YoY; beat guidance in one quarter

Full-year PAT guidance

>25% growth

Raised from 23–24%; Q2 already at 27%

Composite segment growth

+29%

H1 FY27; at high end of 25–30% guidance

Hydrogen pipeline

₹2,500 Cr

3-year target; timing mid-2027

On paper it reads as a blowout: Q2 net profit of ₹148.3 Cr represents 27% year-on-year growth, which already exceeds the company's guided full-year PAT growth of 23–24%. Management responded by raising guidance to >25% on the call. But the real story is not the headline—it's the gap between what was guided and what was delivered, and why that gap means execution is now the credibility test, not the plan.

What the quarter actually delivered

Revenue of ₹1,994.2 Cr is squarely where guidance pointed: full-year ₹2,000 Cr at the start of the year implied Q2 in the ₹1,900–₹2,000 Cr range, and that's what landed. The win is not the headline revenue—it's the mix and profitability. Composite products, the high-margin segment, delivered +29% growth in H1, hitting the top end of the 25–30% guidance band. This is organic (not a one-time item; not inventory MTM). Industrial packaging is steady. PE pipe, the pressure point, grew in line with 20–25% guidance despite monsoon delays in H1. The EBITDA margin stayed at 13.2%, consistent with prior year, and the company carried through to a record EBITDA of ₹265 Cr.

Management's claims vs. what holds up

Reconciling on-call assertions against delivered numbers

Net sales increased 32% YoY

Delivered ₹1,994.2 Cr vs. ₹1,512 Cr prior year = 31.8% growth

Supported

PAT ₹146–148 Cr in Q2

Delivered ₹148.3 Cr (within guidance range, +26.5% YoY vs. 23–24% full-year guide)

Supported; beat full-year guidance in Q2 alone

EBITDA ₹265 Cr

Implied from OPM 13.2% on ₹1,994.2 Cr = ₹262.5 Cr; matches stated ₹265 Cr

Supported

Composite products +29% in H1

High end of 25–30% guidance; strong order book ₹210 Cr validates demand

Supported; segment is running hot

Volume growth 13% H1, tracking 15% full-year target

On pace with prior 'above 15% FY27' minimum guidance; Q2 delivery consistent

Supported; on track

What changed on this call

Guidance was raised. EBITDA growth guidance moved from 19–20% to >20%; PAT growth from 23–24% to >25%. This is a material signal: management is not hedging after a strong quarter, but leaning in. The justification is composite volume momentum and automation efficiency gains now visible in H1 run-rate, plus margin mix improving as capex cycle completion lifts capacity utilization.

Hydrogen opportunity was quantified. A ₹2,500 Cr 3-year hydrogen business pipeline is now on the table, backed by concrete orders: ₹2.5 Cr (NTPC hydrogen locomotive), ₹83 Cr (PSU CNG cascades). The company has PESO approval for Type 4 hydrogen cylinders—a first-mover advantage in India. But the timing is external: demand clarity is pegged to mid-2027, dependent on government order placement and renewable energy initiatives. This is not a misfire; it's a structural tailwind with uncertain near-term unlock.

Ebullient acquisition was deferred. The ₹220 Cr QIP-funded acquisition of Ebullient Plastomers (IBC/packaging synergies) is now on hold pending geopolitical stabilization. This is prudent (West Asia uncertainties warranting caution), but it delays consolidation-driven synergies (7.5–10% EBITDA uplift) by 2–3 years. Capex roadmap remains: ₹350 Cr FY26-27 on track (₹174 Cr H1 spent), normalizing to ₹200–250 Cr post-2027.

The bull-bear ledger

  • Record Q2 PAT (₹148.3 Cr) beats full-year guidance in one quarter—execution credibility confirmed

  • Composite segment +29% (H1), at high end of guidance; ₹210 Cr order book signals sustained demand

  • Hydrogen Type 4 cylinders PESO-approved; ₹2,500 Cr 3-year pipeline with NTPC & PSU orders embedded

  • Capex cycle completion (Morai 480 cascades, Greenpeace conical done) enables margin expansion 13% → 15.5% target

  • Management raised EBITDA/PAT guidance after strong Q2; not hedging despite upside surprise

  • PE pipe margin compressed to 10–12% (raw material inflation 30–40%, EPC contractor cost-pass-through dependency)

  • Middle East business down 25% H1 due to geopolitical tension; 11% of overseas revenue at risk

  • Hydrogen demand realization is external-dependent (government order timing, regulatory approvals); mid-2027 clarity

  • Ebullient acquisition deferred; consolidation synergies delayed 2–3 years; capex/investment flexibility constrained

  • Polymer price volatility remains; 20–25 day cost-pass-through lag effective but not foolproof if cycles shorten

Risks, ranked by how much they should concern a holder

Material concerns ordered by severity for equity holders

Hydrogen commercialization timing (external approval dependency)

Medium

₹2,500 Cr 3-year pipeline and 5-year ₹5,000 Cr composite revenue targets hinge on government order placement and regulatory approval cycles (PESO, ministry). Mid-2027 clarity is a placeholder; delay pushes payback out and defers capex ROIC realization. Market is pricing stock at ₹189.69; high hydrogen leverage could amplify drawdown if timing slips.

PE pipe margin compression (EPC cost-pass-through risk)

Medium

Raw material inflation (30–40%) is being passed to EPC contractors, not fully to end customers. If EPC absorbs costs or government budgets don't expand, Time's 10–12% PE pipe margin is at risk. PE pipe is 40% H1 / 60% H2 seasonal; H2 margin realization will be a key indicator.

Geopolitical exposure (West Asia / Middle East tensions)

Medium

Middle East business (11% of overseas revenue, 4% of total) down 25% H1. Further escalation in the region could extend the headwind. Overseas is 36% of revenue; MENA concentration creates earnings volatility not fully hedged by company actions.

Polymer price volatility & cost-pass-through mechanism failure

Low

The 20–25 day lag between polymer cost inflation and customer price revisions is currently holding, but if commodity cycles accelerate or customers push back, margin compression could hit 13.2% EBITDA margin unexpectedly. Current inflationary environment makes this plausible but not imminent.

Capex execution and ramp delay

Low

Morai plant (480 cascades, ₹430 Cr capex) is ramping post-completion; 6–8 month commercialization cycle assumed. Any construction/commissioning slip could delay 15% volume growth realization and margin improvement timeline.

How the street is positioned

The stock is trading at ₹189.69 as of the report date, sitting -26.1% below its all-time high of ₹256.8, but +23.5% above its 52-week low of ₹153.63. Price is above the SMA20 (₹172.04), SMA50 (₹177.64), and SMA200 (₹182.56), but RSI at 61.6 signals neutral momentum—neither overbought nor oversold. Volume is increasing, suggesting growing interest but not yet conviction.

On the ownership front, FII holdings declined to 8.53% (Q1 FY27) from 10.88% (Q4 FY26), a -2.35 percentage-point drop. This is meaningful: foreign money is trimming exposure ahead of the earnings season and into geopolitical uncertainty. DII holdings ticked up marginally (+0.2pp to 17.57%), and promoters remain steady at 47.56%. The FII outflow is not panic-selling, but it signals hesitation on the hydrogen upside narrative and/or concern over Middle East headwinds. This divergence matters: if the company executes on capex completion and composite growth, FII re-entry becomes a catalyst.

The drawdown from ATH (-26%) in a backdrop of record earnings delivery is a red flag or an opportunity depending on your read: the market is pricing in either hydrogen delay or PE pipe margin erosion, not baseline growth. If guidance is met and hydrogen orders start flowing by mid-2027, the stock could re-rate. If PE pipe margins compress further or Middle East escalates, the 52-week low becomes a risk.

What to watch next

  • 1 · H2 FY27 PE pipe volume and margin realization

    PE pipe is historically 60–65% of annual business in H2 (post-monsoon seasonal strength). Watch order inflow in Q3 and whether margins hold at 10–12% or compress further as raw material inflation stalls. This will clarify whether government Jal Jeevan incentives are offsetting EPC cost-pass-through headwinds.

  • 2 · Morai plant composite cascade ramp and EBITDA margin trajectory

    Greenpeace is commercialized; Morai ramp-up (6–8 months, 480 cascade capacity) is the marginal EBITDA uplift driver. Watch Q3/Q4 FY27 composite volume contribution and whether consolidated EBITDA margin trends toward the 15.5% target. This validates the capex payback thesis.

  • 3 · Hydrogen order pipeline concretization (mid-2027)

    Management pegged mid-2027 for hydrogen demand clarity from India's renewable energy and LPG supply initiatives. Watch for government order announcements, NTPC/PSU cascade procurement timelines, and international hydrogen inquiries from European exhibitions. This will signal whether ₹2,500 Cr 3-year pipeline is on track or faces delay.

Time Technoplast delivered a record quarter that beat its own full-year profit guidance in Q2 alone. This is execution, not luck, and management's decision to raise guidance reflects conviction, not caution. But the stock's 26% drawdown from its all-time high, combined with FII exit, suggests the street is hedging on hydrogen timing and PE pipe margin pressure. The next step-change happens when capex completes (margin expansion) and hydrogen orders materialize (top-line acceleration). Until then, expect the stock to consolidate—steady execution on composite and PE pipe segments is priced in, but the upside (hydrogen + 15.5% EBITDA margin) is discounted.

The single number to track from here: EBITDA margin in Q3/Q4 FY27. If it trends toward 13.8–14.2% (indicating capex completion leverage), the stock re-rates. If it holds at 13.2% (PE pipe compression offsets composite mix), the market's caution is justified, and downside risk is real.

Informational and educational content only. Not investment advice.